hypertension

Accountable Care Organizations

By: Stephanie Chiu and Elissa Tam, PharmD Candidates c/o 2015 -- According to the Dartmouth Atlas project, health care spending…

12 years ago

Pediatric Hypertension

By: Anthony Botte and Tyler Valente, PharmD Candidates c/o 2016 - Diseases which are prevalent within the pediatric population require…

12 years ago

Quantifying the Benefits of Pharmacist Prescribing Power

By Davidta Brown, Senior Staff Editor - The idea of granting pharmacists the right to prescribe, as well as to…

12 years ago

Riociguat (Adempas®) New Drug for Pulmonary Hypertension

By: Hayeon Na, Co-Copy Editor [Content-Focused] - On October 8th of 2013, Bayer’s new drug riociguat (Adempas®) was approved for…

12 years ago

Surviving APPE Rotations

By: Aleena Cherian, Co-Copy Editor [Graphics-Focused] and Jenny Prakash, PharmD Candidate c/o 2014 - Starting your rotations in 5th year…

12 years ago

Say Hello to JNC8: New Hypertension Guidelines

By: Frances Trosa PharmD Candidate c/o 2015 - After much anticipation, the report from the Eighth Joint National Committee (JNC…

12 years ago

Direct Association of HIV and Early Kidney Damage in Women

By: Elizabeth Kopec, PharmD Candidate c/o 2014, South University School of Pharmacy at Columbia, SC - Human immunodeficiency virus (HIV)…

12 years ago

Newly Approved: Macitentan (Opsumit®)

By: Rebecca Gilene, PharmD Candidate c/o 2014, St. Louis College of Pharmacy - The FDA approved macitentan (Opsumit®) on October…

13 years ago

Ponatinib Taken Off the Market

By: Sherine Jaison, PharmD Candidate c/o 2015 -  The leukemia chemotherapy drug ponatinib (Iclusig) has just been taken off the…

13 years ago

Moving Towards Provider Status: An Interview with Sandra Leal

By: Hayeon Na, Co-Copy Editor and Sang Hyo Kim, Staff Editor - In Volume 1 Issue1 of the Rho Chi…

13 years ago

The Third Wheel or the Steering Wheel? Pharmacists on the Healthcare Team

By: Joshua Bliss, PharmD Candidate c/o 2016 - Doctor - a word often utilized by both professionals and the general…

13 years ago

New Treatment for a Deficiency in Iron-Supplement Therapies

By: Davidta Brown, Staff Editor - For the estimated 7.5 million individuals in the United States living with iron deficiency…

13 years ago

Olmesartan Medoxomil Label Revision

By: David Ong, PharmD Candidate c/o 2014 - Manipulating the renin-angiotensin system is one of the many ways drugs are…

13 years ago

Two New Agents for the Treatment of Obesity

By: Nathan Trustman, PharmD Candidate c/o 2013, AMSCOP at LIU - Obesity is defined as having a body mass index…

13 years ago

FDA Approves Apixaban For Nonvalvular Atrial Fibrillation

By: Alexandra Alleva, PharmD candidate c/o 2013 - As of December 28th, Bristol-Myers Squibb and Pfizer's brand name oral anticoagulant,…

13 years ago

Tackling America’s Drug Shortage Crisis

By: John S Lim, PharmD Candidate c/o 2013 - America’s focus on healthcare, as well as its position as one…

14 years ago

Adverse Events from Ingestion of OTC Eye Drops and Nasal Sprays

By Tasnima Nabi, PharmD Candidate c/o 2016 - The FDA has issued warnings on accidental ingestion of over-the-counter eye drops…

14 years ago

Are You Prepared for RSV Season?

By: Mahdieh Danesh Yazdi, Associate Student Editor - Many of us have prepared for influenza season by receiving the flu…

14 years ago

Antiplatelet Use Following Acute Coronary Syndromes

By: Addolorata Ciccone, Co-Copy Editor - Acute Coronary Syndromes Acute coronary syndrome (ACS) is a myocardial ischemia caused by obstruction…

14 years ago

Indications for Dialysis: A Mnemonic And Explanation

By: Neal Shah, Co-Editor-in-Chief -  Dialysis is the removal of substances from intravascular circulation by filtration.1  Typically, dialysis is ordered…

14 years ago

Meet the new Beta 3 Agonist: Mirabegron (Myrbetriq®)

By: Steve P. Soman - Mirabegron (Mybetriq®), known also by the brand name Betanis®in Japan, is a new once daily…

14 years ago

Matching Challenge: Over-the-Counter Products

By Mohamed Dungersi, Associate Student Editor - Match the following herbal products with their natural source and reason for use:…

14 years ago

Matching Challenge: Look-Alike, Sound-Alikes

By: Addolorata Ciccone, Pharm.D. Candidate c/o 2013 - The following medications are easily confused.  Try to match each one with…

14 years ago

Risk versus Benefit: Prescription to Over the Counter Medications

By: Maria A. Sorbera, Pharm.D. Candidate c/o 2013 -   Maria Sorbera was the 2011-2012 President of the Rho Chi…

14 years ago

Role of Calcium Channel Blockers and Beta Blockers in CHF

By: Lunbao Huang Pharm D. Candidate c/o 2013 - The seventh report of the Joint National Committee on high blood…

14 years ago

CHF, a Rare but Serious Presentation of Graves’ disease

By: James Schurr, Pharm.D. Candidate c/o 2014 - Graves’ disease is an autoimmune disorder that results in a state of…

14 years ago

FDA Approves Edarbyclor®

By: Gokul Kalla, Pharm.D. Candidate c/o 2013 - Hypertension is a chronic disease that affects one out of every three…

14 years ago

Clevidipine in the Management of Hypertensive Emergency

By: Neal Shah - Defined by the Joint National Committee, hypertension (HTN) is a systolic blood pressure (SBP) greater than…

14 years ago

Ivabradine: A Novel I(f) Blocker for Stable Angina

By: Neal Shah - Part I:              Preface. Part II:             Brief review of cardiac electrophysiology. Part III:           Ivabradine as a novel…

15 years ago